BIOCRYST PHARMACEUTICALS INC. - COMMON STOCK
7.8350
10-1月-25 09:41:17
15 分の遅延
株式
-0.2150
-2.67%
本日の幅
7.6200 - 8.4900
ISIN
N/A
ソース
NASDAQ
-
BioCryst to Present at Upcoming Investor Conferences
01 6 2022 06:00:15 提供 Nasdaq GlobeNewswire
-
BioCryst to Present at Upcoming Investor Conferences
06 5 2022 06:00:28 提供 Nasdaq GlobeNewswire
-
BioCryst Reports First Quarter 2022 Financial Results and Upcoming Key Milestones
05 5 2022 06:00:11 提供 Nasdaq GlobeNewswire
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04 5 2022 15:15:39 提供 Nasdaq GlobeNewswire
-
27 4 2022 06:00:00 提供 Nasdaq GlobeNewswire
-
BioCryst to Report First Quarter 2022 Financial Results on May 5
21 4 2022 06:00:52 提供 Nasdaq GlobeNewswire
-
BioCryst to Present at Upcoming Investor Conference
11 4 2022 07:30:49 提供 Nasdaq GlobeNewswire
-
BioCryst Pauses Enrollment in BCX9930 Clinical Trials
08 4 2022 08:15:13 提供 Nasdaq GlobeNewswire
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05 4 2022 06:15:42 提供 Nasdaq GlobeNewswire
-
BioCryst to Present at Upcoming Investor Conferences
03 3 2022 06:00:01 提供 Nasdaq GlobeNewswire